Hosted on MSN18d
MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that the company can move forward with ...
Monogram Technologies received Food and Drug Administration 510(k) clearance for its mBôS TKA System for total knee replacements and will now work toward commercializing the system, the Austin, ...
Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and ...
Monogram May Market the Monogram mBôs TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating ...
Monogram received FDA 510(k) clearance for its robotic-assisted total knee arthroplasty system, Monogram mBôs TKA. The company plans initial placements with key surgeons and aims to expand its ...
Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This determination means that Monogram may market the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results